Thermo Fisher Emphasizes Informatics and Sample Prep Portions of Proteomics Portfolio

During its Q2 earnings call, officials cited the company's Proteome Discoverer software and acquisition of nano-LC firm Proxeon as developments that will allow it to better leverage its mass spec offerings.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.